[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,780
Citations 0
News From the Centers for Disease Control and Prevention
October 11, 2016

HPV Vaccination Rates Lag in Teens

JAMA. 2016;316(14):1440. doi:10.1001/jama.2016.14253

Vaccination rates against human papillomavirus (HPV) among US teens remain stubbornly lower than those of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine and quadrivalent meningococcal conjugate vaccine (MenACWY), according to a recent CDC report.

Data from a 2015 national survey involving more than 22 000 teens aged 13 to 17 years showed that overall, coverage with at least 1 dose of HPV vaccine was 56.1% and 45.4% with 2 or more doses; coverage with the full 3-dose series was 34.9%. In comparison, coverage with 1 or more doses of Tdap was 86.4%, and coverage was 81.3% with at least 1 dose of MenACWY. All 3 vaccines are routinely recommended at age 11 to 12 years.

First Page Preview View Large
First page PDF preview
First page PDF preview